MammographyBreastBreast NeoplasmsCarcinoma, Ductal, BreastBreast DiseasesMass ScreeningEarly Detection of CancerReceptors, EstrogenCell Line, TumorBreast Self-ExaminationReceptor, erbB-2TamoxifenReceptors, ProgesteroneGene Expression Regulation, NeoplasticPrognosisNeoplasm InvasivenessCarcinoma, Intraductal, NoninfiltratingNeoplasm MetastasisBreast Neoplasms, MaleNeoplasm StagingRisk FactorsTumor Markers, BiologicalMastectomyCarcinoma, LobularGenes, BRCA1Antineoplastic Agents, HormonalSensitivity and SpecificityPostmenopauseChemotherapy, AdjuvantAntineoplastic AgentsUnited StatesNeoplasm ProteinsX-Ray FilmAge FactorsGenetic Predisposition to DiseasePremenopauseFollow-Up StudiesCase-Control StudiesSurvival AnalysisProspective StudiesMCF-7 CellsCarcinomaRetrospective StudiesMice, NudeRiskBreast FeedingGenes, BRCA2Lymphatic MetastasisRisk AssessmentAntineoplastic Combined Chemotherapy ProtocolsRadiographic Image Interpretation, Computer-AssistedIncidenceTumor Cells, CulturedEstrogen Receptor alphaDrug Resistance, NeoplasmPalpationOdds RatioEstrogensNeoplasm Recurrence, LocalMastectomy, SegmentalMenopauseFalse Positive ReactionsFibrocystic Breast DiseaseOvarian NeoplasmsBRCA2 ProteinMammary Neoplasms, ExperimentalDisease-Free SurvivalNeoplasms, Hormone-DependentSurvival RateImmunohistochemistryRadiologyGene Expression ProfilingSurvivorsLogistic ModelsCell ProliferationRegistriesBRCA1 ProteinAxillaQuestionnairesReproducibility of ResultsMultivariate AnalysisCarcinoma in SituCohort StudiesMammary Glands, HumanReverse Transcriptase Polymerase Chain ReactionCarcinoma, DuctalNipplesTime FactorsPredictive Value of TestsAromatase InhibitorsNeoplasmsRNA, MessengerEstrogen AntagonistsLung NeoplasmsSEER ProgramTreatment OutcomeDisease ProgressionGenes, erbB-2Prostatic NeoplasmsPatient Acceptance of Health Care